CCI to examine competition part of deals, RBI prudential aspects.
While the peak holiday season failed to bring in much business to the hotel industry, the online travel booking space has done reasonably well.
Work to begin after that on corrective measures to meet US regulator's requirements.
USFDA has extended the timeline for granting tentative approval to generic drug applications filed under Para IV of its rules by 10 months.
Sun Pharma could have to withdraw cancer drug as J&J re-enters after temporary eclipse
Now, the companies need to get National Pharmaceutical Pricing Authority's nod for changing medicine composition. If they flout norms, government will take penal action.
Maruti Suzuki India Limited (MSIL), which witnessed labour unrest at its Manesar facility, is set to complete the process of regularisation of contract workers at the unit by November-end.
Going all out to market the all new Alto 800, pricing the base variant of the new car lower than the outgoing model, Maruti Suzuki India Ltd (MSIL), today said it will start exporting the car from Gujarat's Mundra port from December this year. The first export market is likely to be Chile in South America.
GoM had proposed a new pricing mechanism, but judges had said at an earlier hearing the current formula should stay.
Ranbaxy was scheduled to launch its drug on September 21, the day Diovan's patent expired.
The move is significant, as this may prompt investigating agencies to take a look at the fresh accounting statements to be filed by the company to RoC, before taking a final call.
It was in 2005, India changed its patent law and started granting patents in medicines.
The prices of essential medicines may drop, as the National Pharmaceutical Pricing Authority (NPPA) has made significant changes in its norms to rationalise price approvals.
Orders surprise inspections at chemists and pharma stores.
As expected, land prices in the region have shot through the roof in the last three to four months, rising about 12 times compared to prices a couple of years earlier.
CCI, sector regulators may consult each other if jurisdictions overlap
Moolchand Healthcare Pvt Ltd, the corporate entity formed by the group in 2006 with expansion in mind, is on an acquisition spree for hospital chains, IVF (in vitro fertilisation) clinics and pathological laboratories.
This helps consumers check the authenticity of drugs simply by sending SMSes.
Financial pressure on the parent company triggered the move.
Import alert on unit-6 facility might be lifted by FDA by Sept.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances